Antibody Responses Following Primary Immunization with the Recombinant Herpes Zoster Vaccine (Shingrix<sup>®</sup>) in VZV Seronegative Immunocompromised Adults
<b>Background:</b> Immunocompromised patients are at risk of severe varicella zoster virus (VZV) infection and reactivation. In VZV seronegative immunocompromised persons, live-attenuated VZV vaccination is contraindicated, thus the recombinant herpes zoster vaccine (rHZV) remains a safe...
Saved in:
| Main Authors: | Andrea Wessely, Ines Zwazl, Melita Poturica, Lukas Weseslindtner, Michael Kundi, Ursula Wiedermann, Angelika Wagner |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-07-01
|
| Series: | Vaccines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-393X/13/7/737 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of anti-VZV IgG levels on Parkinson’s disease risk and progression: a Mendelian randomization analysis
by: Jinxing Sun, et al.
Published: (2025-04-01) -
A rare case of acute liver failure due to disseminated Varicella-Zoster Virus (VZV) infection
by: Harris T. Feldman, et al.
Published: (2025-01-01) -
Evidence of Varicella Zoster Virus Reactivation in Children With Arterial Ischemic Stroke: Results of the VIPS II Study
by: Heather J. Fullerton, et al.
Published: (2025-03-01) -
Expanded spectrum of varicella disease and the need for vaccination in India
by: Padma Srikanth, et al.
Published: (2024-12-01) -
New Approach for Diagnostics of VZV Infection by Using Real-Time PCR
by: H. Ph. Pham, et al.
Published: (2016-10-01)